Insider Transactions in Q4 2025 at Intellia Therapeutics, Inc. (NTLA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2025
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,557
+0.81%
|
$51,342
$6.83 P/Share
|
|
Dec 11
2025
|
John M Leonard President and CEO |
SELL
Open market or private sale
|
Direct |
88,146
-2.66%
|
$793,314
$9.52 P/Share
|
|
Dec 11
2025
|
John M Leonard President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
49,959
+4.24%
|
$299,754
$6.83 P/Share
|
|
Oct 01
2025
|
Michael P Dube VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,871
-3.27%
|
$31,807
$17.38 P/Share
|
|
Oct 01
2025
|
Birgit C Schultes EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
31
-0.03%
|
$527
$17.38 P/Share
|